GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                            
                                
                                                                Synonyms: Example 161 [WO2011153942A1]
                                 
                                                         
                            Compound class: 
                                                            Synthetic organic
                                 
                                
                                    
                                        Comment: We obtained the chemical structure for sacibertinib from the WHO's proposed INN list 127 (21 July 2022). In this document it was described as a tyrosine kinase inhibitor and antineoplastic. This same chemical structure is claimed in patent WO2011153942A1 [1]. Inventions of this patent are described as inhibitors of erbB family receptor tyrosine kinases, in particular of EGFR and Her2 (ERBB2).
                                    
                                 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                    
                                    
                                     | 
                                    
                                        
                                         
  | 
                                    
                                
                                |||||||||||||||||||||||||||||||||||
Classification ![]()  | 
                                                    |
| Compound class | Synthetic organic | 
IUPAC Name ![]()  | 
                                                        
| (E)-N-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-[(3S)-oxolan-3-yl]oxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide | 
International Nonproprietary Names ![]()  | 
                                                        |
| INN number | INN | 
| 12300 | sacibertinib | 
Synonyms ![]()  | 
                                                        
| Example 161 [WO2011153942A1] | 
Database Links ![]()  | 
                                                        |
| CAS Registry No. | 1351941-69-9 (source: WHO INN record) | 
| GtoPdb PubChem SID | 472319212 | 
| PubChem CID | 89496273 | 
| Search Google for chemical match using the InChIKey | ZGYIXVSQHOKQRZ-COIATFDQSA-N | 
| Search Google for chemicals with the same backbone | ZGYIXVSQHOKQRZ | 
| Search PubMed clinical trials | sacibertinib | 
| Search PubMed titles | sacibertinib | 
| Search PubMed titles/abstracts | sacibertinib | 
| UniChem Compound Search for chemical match using the InChIKey | ZGYIXVSQHOKQRZ-COIATFDQSA-N | 
| UniChem Connectivity Search for chemical match using the InChIKey | ZGYIXVSQHOKQRZ-COIATFDQSA-N |